No, if the Lancet publication did nothing for PPS, this news wouldn't have either. Gonna have to wait for commercialization in 2018. I have no probs holding this one. I think the name change is ultimately positive though. Now when people google the name of the company they won't be bombarded with age old legacy issues.
11/14/14 at 1:34pm